U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: over 10,000 records

Showing results for "question".

  1. Update Topic CER 31 Clostridium difficile NSD FINAL (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/c-diff-infections-nomination-140925.pdf
    February 19, 2014 - Topic Description Key Questions: Key Question 1: How do different methods for detection of toxigenic … B § Gene detection tests versus immunoassays for toxins A and B § Patient characteristics Key Question … alcohol gel § Disinfection § Sustainability § Risk factors § Multiple component strategies Key Question … treatment § Strain of organism § Patient characteristics § Resistance of other pathogens Key Question

  2. Topic 0613 Tympanostomy Tubes NSD FINAL (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0765-150129.pdf
    November 03, 2014 - Key Question #1: What is the comparative effectiveness of tympanostomy tubes in children with chronic … hearing levels (HLs); speech and language improvement; health-related quality of life (HRQoL) Key Question … Key Questions from Nominator: Key Question … indications for tympanostomy; patient satisfaction with the change in hearing following surgery Key Question … of TTO duration or recurrence; prevention of other complications; school absenteeism; HRQoL Key Question

  3. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
    March 01, 2011 - Below we provide additional summary information for selected comparisons of interest by key question, … Key Question 1: Intermediate Outcomes Intermediate clinical outcomes were the most frequently evaluated … Therefore, most comparisons for this key question had a low strength of evidence. … Key Question 3: Adverse Events and Side Effects This Key Question was addressed by 107 studies. … Key Question 4: Differences in Subgroups Twenty-eight studies applied to Key Question 4.

  4. Final Research Plan: Prostate Cancer: Screening | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prostate-cancer-screening
    April 28, 2016 - Key question 1 addresses the effectiveness of PSA-based screening in reducing mortality and morbidity … Key question 2 addresses the harms of PSA-based screening and diagnostic workup (i.e., biopsy). … Key question 4 addresses the harms of treatment of early-stage or screen-detected prostate cancer. … Finally, key question 5 addresses the effectiveness of prostate cancer risk calculators combined with … Contextual Question 2 (originally about treatment preferences) was replaced with a question about the

  5. Liver-Cancer Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
    October 01, 2014 - Key Question 1. … Key Question 2. … Key Question 3. … Key Question 1. … Key Question 2.

  6. Archived: Evidence Summary: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/genital-herpes-screening-november-2016
    December 20, 2016 - Key Question 1b. … Key Question 3b. … Key Question 5a. … Key Question 5b. … Key Question 6b.

  7. Magnus D et al. 2002 "GPs' views on computerized drug interaction alerts: questionnaire survey." | Digital Healthcare Research

    digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/magnus-d-et-al-2002-gps
    January 01, 2002 - Question: "How often do drug interaction alerts change your initial prescribing decisions?" … Question: "How often do drug interaction alerts provide you with information that you already know?" … Question: "How often do drug interaction alerts provide information that is irrelevant to the patient … Question: "How often do you feel annoyed by the drug interaction alert messages?"

  8. Cnf-Nffq (pdf file)

    meps.ahrq.gov/data_stats/nhc/cnf-nffq.pdf
    September 30, 1997 - There are three potential elements to any question: instructions before the question, the question itself … after the question categories. … MANAGEMENT SYSTEM SPECS: If DK or RF are entered in root question, flag FAVERIF4 root question for retrieval … MANAGEMENT SYSTEM SPECS: If DK is entered in root question, flag FAVERIF4 root question as still MISSING … MANAGEMENT SYSTEM SPECS: If DK is entered in root question, flag FAVERIF5 root question as still MISSING

  9. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
    April 06, 2010 - The Key Questions Key Question 1: In adults age 18 or older with type 2 diabetes mellitus, what is the … Outcomes for each question The outcomes for Key Question 1 are: • HgbA1c • Weight • Low density … □ For Key Question 1, we included the following outcomes: HgbA1c, weight, and serum lipid levels ( … □ For Key Question 3, we included the following outcomes: hypoglycemia, liver injury, congestive … □ For Key Question 1, we included only RCTs.

  10. Frequently Asked Questions about Collecting R/E/L Data (pdf file)

    hcup-us.ahrq.gov/datainnovations/raceethnicitytoolkit/ca13.pdf
    January 01, 2009 - racial categories and respond by indicating “Other” or by stating that they already responding the question … (by answering the ethnicity question). … and “White” to the race question. … Question #3 on the sample patient demographic questionnaire asks patients who indicate more than one … based on observation, and should not push the issue with patients who do not wish to answer this question

  11. Nephropathy-Contrast-Induced Research-Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_research-protocol.pdf
    October 01, 2013 - dose/volume and number of doses) Comparators Key Question 1 and Key Question 2 (see Table 2) ● … Key Question 3 and Key Question 4 (see Table 3) ● IOCM versus LOCM ● LOCM versus LOCM ● IOCM (by … Setting ● Key Question 1 through Key Question 4 ● Inpatient and outpatient populations Source: www.effectivehealthcare.ahrq.gov … Major prevention interventions and comparisons for Key Question 1 and Key Question 2 (These are the … Major contrast media and comparisons for Key Question 3 and Key Question 4 (These are the important

  12. Archived: Final Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan98/statin-use-in-adults-preventive-medication-november-2016
    May 02, 2014 - assesses lipid screening and its effects on CHD- and CVA-related morbidity and mortality outcomes (Key Question … An arrow in the lipid screening area assesses different screening strategies (Key Question 3). … An arrow from the statins treatment area of the framework assesses associated harms (Key Question 2). … treatment also address how benefits and harms vary according to the potency of statin treatment (Key Question … In response to public comments, a key question on how benefits and harms vary according to statin therapy

  13. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
    January 01, 2007 - 3 Key Question 2. … Key Question 3. … Key Question 1. … Key Question 2. … Key Question 3.

  14. Mass-Casualty-Events-Scarce-Resources Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mass-casualty-events-scarce-resources_executive.pdf
    June 01, 2012 - This report addresses the following Key Questions: Key Question 1. … Key Question 2. … Key Question 3. … Key Question 4. … Our data extraction approach was tailored to each Key Question.

  15. Template for Reports Developed (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
    October 26, 2012 - The PICOTS on this question will depend on study question and design 2.3 To what extent … The PICOTS on this question will depend on study question and design 2.3 To what extent … The study design evaluations for this question was combined with research question number 4.1 as … question number 4.1 below. … The study design evaluations for this question was combined with research question number 2.1 as they

  16. Topic 0614 Tonsillectomy NSD FINAL CC (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0768-141211.pdf
    October 23, 2014 - Key Question #1: What is the comparative effectiveness of tonsillectomy in children with recurrent throat … Outcome(s): Number of throat infections, complications of infection, or complications of surgery Key Question … Key Question … In consultation with our clinical reviewer, the scope of this topic from the original nominator question

  17. Archived: Update on the Methods of the U.S. Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit: Carotid Artery Stenosis: Screening, December 2007 | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/update-on-the-methods-of-the-us-preventive-services-task-force-estimating-certainty-and-magnitude-of-net-bene%EF%AC%81t/carotid-artery-stenosis-screening-december-2007
    December 15, 2007 - New terms have been added to describe the USPSTF's judgment about the evidence for each key question: … The overarching question that the Task Force seeks to answer for every preventive service is whether … Each arrow in the framework defines a key question, and each key question represents a link in the chain … How many studies have been conducted that address the key question(s)? How large are the studies? … Note: CEA = carotid endarterectomy; KQ = key question.

  18. Menopause Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_executive.pdf
    March 01, 2015 - Key Question 2. … Key Question 3. … Key Question 4. … KQ = Key Question. Figure A. … Key Question 3 was a two-part question examining adverse events and long- term effects of nonhormone

  19. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pelvic-pain-surveillance-151130.pdf
    July 10, 2015 - Key Question 2. … Key Question 3. … Key Question 4. … Key Question 5. … Key Question 2.

  20. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/thromboembolism-update_research-protocol.pdf
    February 17, 2016 - Question 2 (update of original Key Question 6): In patients undergoing major orthopedic surgery (total … Question 3 (new Key Question based on original Key Question 8): In patients undergoing major orthopedic … Question 4 (update of original Key Question 7 plus expansion): In patients undergoing major orthopedic … Question 5 (new Key Question): In patients undergoing major orthopedic surgery (total hip or knee replacement … Question 6 (new Key Question): In patients undergoing major orthopedic surgery (total hip or knee replacement
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

www.ahrq.gov (4887)

psnet.ahrq.gov (2470)

hcup-us.ahrq.gov (2276)

effectivehealthcare.ahrq.gov (1932)

digital.ahrq.gov (1375)

www.uspreventiveservicestaskforce.org (937)

meps.ahrq.gov (434)

cdsic.ahrq.gov (184)

integrationacademy.ahrq.gov (99)

cds.ahrq.gov (57)

pso.ahrq.gov (33)

datatools.ahrq.gov (28)

cahpsdatabase.ahrq.gov (14)

qualityindicators.ahrq.gov (7)